Early Detection


Surgery offers pancreatic cancer patients the best chance for long-term survival, yet currently less than 20% of patients are eligible upon diagnosis. Unfortunately, the majority of pancreatic cancers are identified after the disease has metastasized, or spread to other organs, making treatment more challenging.

But Lustgarten-supported researchers are always up for a challenge. We are committed to funding the world’s best earlier detection research, giving patients and their families more help—and more hope—than ever before.

Thanks for signing up!
Tell us a little more about yourself: